Next Article in Journal
Lipopolysaccharide-Induced Acute Kidney Injury Is Dependent on an IL-18 Receptor Signaling Pathway
Next Article in Special Issue
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Previous Article in Journal
Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
Previous Article in Special Issue
Role of MicroRNAs in TGF-β Signaling Pathway-Mediated Pulmonary Fibrosis
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(12), 2776; https://doi.org/10.3390/ijms18122776

The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility

1
First Department of Medicine, UKSH, Campus Lübeck, 23538 Lübeck, Germany
2
Department of General and Thoracic Surgery, UKSH, Campus Kiel, 24105 Kiel, Germany
3
Department of General, Visceral and Vascular Surgery, Jena University Hospital, 07747 Jena, Germany
4
Institute of Pharmacology, Department of General Pharmacology, University Medicine Greifswald, 17487 Greifswald, Germany
*
Author to whom correspondence should be addressed.
Received: 24 October 2017 / Revised: 8 December 2017 / Accepted: 15 December 2017 / Published: 20 December 2017
(This article belongs to the Special Issue TGF-beta Family in Fibrosis and Cancer)
View Full-Text   |   Download PDF [2793 KB, uploaded 20 December 2017]   |  

Abstract

Background: Recently, the expression of proteinase-activated receptor 2 (PAR2) has been shown to be essential for activin receptor-like kinase 5 (ALK5)/SMAD-mediated signaling and cell migration by transforming growth factor (TGF)-β1. However, it is not known whether activation of non-SMAD TGF-β signaling (e.g., RAS–RAF–MEK–extracellular signal-regulated kinase (ERK) signaling) is required for cell migration and whether it is also dependent on PAR2. Methods: RNA interference was used to deplete cells of PAR2, followed by xCELLigence technology to measure cell migration, phospho-immunoblotting to assess ERK1/2 activation, and co-immunoprecipitation to detect a PAR2–ALK5 physical interaction. Results: Inhibition of ERK signaling with the MEK inhibitor U0126 blunted the ability of TGF-β1 to induce migration in pancreatic cancer Panc1 cells. ERK activation in response to PAR2 agonistic peptide (PAR2–AP) was strong and rapid, while it was moderate and delayed in response to TGF-β1. Basal and TGF-β1-dependent ERK, but not SMAD activation, was blocked by U0126 in Panc1 and other cell types indicating that ERK activation is downstream or independent of SMAD signaling. Moreover, cellular depletion of PAR2 in HaCaT cells strongly inhibited TGF-β1-induced ERK activation, while the biased PAR2 agonist GB88 at 10 and 100 µM potentiated TGF-β1-dependent ERK activation and cell migration. Finally, we provide evidence for a physical interaction between PAR2 and ALK5. Our data show that both PAR2–AP- and TGF-β1-induced cell migration depend on ERK activation, that PAR2 expression is crucial for TGF-β1-induced ERK activation, and that the functional cooperation of PAR2 and TGF-β1 involves a physical interaction between PAR2 and ALK5. View Full-Text
Keywords: ALK5; ERK; cell migration; PAR2; SMAD; transforming growth factor-β ALK5; ERK; cell migration; PAR2; SMAD; transforming growth factor-β
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Share & Cite This Article

MDPI and ACS Style

Ungefroren, H.; Witte, D.; Fiedler, C.; Gädeken, T.; Kaufmann, R.; Lehnert, H.; Gieseler, F.; Rauch, B.H. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility. Int. J. Mol. Sci. 2017, 18, 2776.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top